Literature DB >> 27356830

Tricyclic Antidepressants: What to Choose and Which Dose?

Daniel Keszthelyi1, Ad A Masclee1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27356830     DOI： 10.1038/ajg.2016.104

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

Review 1.  Tricyclic antidepressant pharmacology and therapeutic drug interactions updated.

Authors:  P K Gillman
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

2.  Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial.

Authors:  Julajak Limsrivilai; Phunchai Charatcharoenwitthaya; Nonthalee Pausawasdi; Somchai Leelakusolvong
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

3.  Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

Authors:  Douglas A Drossman; Brenda B Toner; William E Whitehead; Nicholas E Diamant; Chris B Dalton; Susan Duncan; Shelagh Emmott; Valerie Proffitt; Donna Akman; Karen Frusciante; Terry Le; Kim Meyer; Barbara Bradshaw; Kristi Mikula; Carolyn B Morris; Carlar J Blackman; Yuming Hu; Huanguang Jia; Jim Z Li; Gary G Koch; Shrikant I Bangdiwala
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

4.  Desipramine pharmacokinetics in Chinese and Caucasian volunteers.

Authors:  M V Rudorfer; E A Lane; W H Chang; M D Zhang; W Z Potter
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

5.  Low-Dose Tricyclics for Esophageal Hypersensitivity: Is it all Placebo Effect?

Authors:  Laurie Keefer; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2016-02       Impact factor: 10.864

6.  Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial.

Authors:  Nicholas J Talley; John E Kellow; Philip Boyce; Christopher Tennant; Sandy Huskic; Michael Jones
Journal:  Dig Dis Sci       Date:  2007-05-15       Impact factor: 3.199
  6 in total
  1 in total

1.  Response to Keszthelyi et al.

Authors:  Somchai Leelakusolvong; Julajak Limsrivilai; Phunchai Charatcharoenwitthaya; Nonthalee Pausawasdi
Journal:  Am J Gastroenterol       Date:  2016-07       Impact factor: 10.864
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.